sonomabio.comHealthcareFounded: 2019Funding to Date: $335.1MM
Sonoma Biotherapeutics is a biotech company focused on the development of adoptive Treg cell therapies for autoimmune and inflammatory diseases.
View Enterprise Value for Sonoma Biotherapeutics.